Letter to the editor: Autoimmune hepatitis after COVID-19 vaccination: A rare adverse effect?
- PMID: 34528278
- PMCID: PMC8653275
- DOI: 10.1002/hep.32156
Letter to the editor: Autoimmune hepatitis after COVID-19 vaccination: A rare adverse effect?
Conflict of interest statement
Nothing to report.
Figures
Comment in
-
Letter to the editor: "Autoimmune hepatitis after COVID-19 vaccination".Hepatology. 2022 Mar;75(3):756. doi: 10.1002/hep.32249. Epub 2021 Dec 18. Hepatology. 2022. PMID: 34797931 Free PMC article. No abstract available.
-
Reply.Hepatology. 2022 Mar;75(3):756-757. doi: 10.1002/hep.32248. Epub 2021 Dec 18. Hepatology. 2022. PMID: 34797940 Free PMC article. No abstract available.
-
Letter to the editor: Exacerbation of autoimmune hepatitis after COVID-19 vaccination.Hepatology. 2022 Mar;75(3):757-759. doi: 10.1002/hep.32269. Epub 2021 Dec 19. Hepatology. 2022. PMID: 34862637 Free PMC article. No abstract available.
-
Letter to the editor: Autoimmune hepatitis after COVID-19 vaccination: Need for population-based epidemiological study.Hepatology. 2022 Mar;75(3):759-760. doi: 10.1002/hep.32280. Epub 2022 Jan 5. Hepatology. 2022. PMID: 34904265 No abstract available.
References
-
- COVID‐19 mRNA Pfizer‐BioNTech vaccine analysis print. Accessed September 3, 2021. https://www.gov.uk/government/publications/coronavirus‐covid‐19‐vaccine‐...
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources